60 likes | 73 Views
Global Market Insights added a new report on global HLA Typing for Transplant Market to its research database. The report focuses on global major leading players with information such as company profiles, growth, product segment, technology segment, end user segment and region.
E N D
HLA Typing for Transplant Market Outlook, Strategies, Manufacturers, Countries, Type and Application, Global Forecast To 2028 © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Global Market Scenario of HLA Typing for Transplant Market Peripheral Interventions Market • Global Market Insights recently introduced report on Global HLA Typing for Transplant Market report is an in-depth study providing complete analysis of the industry for the period 2022 to 2028. It provides complete overview of the industry considering all the major industry trends, market dynamics and competitive scenario. • The HLA typing for transplant market is estimated to register significant expansion by 2028 due to the expanding global geriatric population. • Studies have indicated that HLA (human leukocyte antigen) typing could be feasible to match umbilical cord blood (UCB) transplant recipient pairs in developing countries that have limited resources. Increasing prevalence of chronic diseases requiring organ transplantation has accelerated product adoption. In addition, recent technological advancements and R&D activities have augmented industry uptake over the past few years. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Continue:- • Notably, industry players have been implementing strategic initiatives to tap into emerging trends in the market, which has positively impacted overall business dynamics. For instance, in January 2022, Immucor, Inc., a leading provider of transplantation and transfusion services, launched its novel HLA typing software dubbed the MIA FORA NGS EXPRESS HLA Typing Software. The enhanced HLA typing software has been designed to include essential features, such as additional hardware and operating system support, shorter run-time, and a comprehensive summary page. • The HLA typing for transplant market has been segregated on the basis of end-use, technology, application, product and services, and region. From the technology perspective, the market has further been divided into molecular assays and non-molecular assays. The non-molecular assays sub-segment held a market share of nearly 16.5% in 2021 and is speculated to amass significant gains over the assessment period. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
360° Industry Analysis • In terms of product and services, the HLA typing for transplant market has been classified into instruments, services, reagents and consumables, and software. In 2021, the services segment registered a valuation of around USD 93.4 million in 2021 and is expected to witness steady growth through the study timeline. • With respect to application, the market has been bifurcated into research and diagnostics. The HLA typing for transplant market from the research sub-segment is anticipated to reach a valuation of more than USD 241.7 million by the end of 2028. © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Competitive Analysis: • Abbott • Bio-Rad Laboratories • CareDx • Qiagen N.V. • Thermo Fischer Scientific • F. Hoffmann-La Roche Ltd • Illumina Inc • Luminex Corporation and Immucor • Inc • Browse Complete Summary of this report @ https://www.gminsights.com/industry-analysis/hla-typing-for-transplant-market © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com
Stay In Touch You can visit us at: www.gminsights.com Thank You…! © 2022 Global Market Insights, Inc. USA. All Rights Reserved www.gminsights.com